Stereotactic Body Radiation Therapy Training Program 2023 (RP2307A-071223)

July 12, 2023 to July 14, 2023

The primary focus of this CME course is to help oncology programs in both large and small centers, academic and community practice, learn about the proper implementation of a viable and effective SBRT treatment practice. Covered topics will include the evolution of SBRT from roots in image-guided tumors in the body, guidelines for proper treatment conduct, billing and compliance, physics and dosimetry of SBRT, clinical outcomes and treatment patterns in spine, liver, lung, GI and GU cancers, and description of various treatment platforms in clinical operation.

Target Audience

This course is designed for radiation oncologists, medical physicists, medical dosimetrists, administrators and radiation therapists interested in implementing SBRT into clinical practice.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Examine the rationale and basic biology for delivering ablative doses of radiation to demarcated tumors using SBRT and image-guided techniques
  • Implement "on or off treatment" protocol based upon mature clinical data
  • Identify treatment delivery options for initiating a clinical SBRT program at both large and small centers.
  • Demonstrate hands-on skills in the identification and delivery of SBRT treatments via simulated exercises.
  • Explain quality assurance and regulatory compliance requirements for implementing a clinical SBRT program.
Course summary
Available credit: 
  • 19.50 AMA
  • 19.50 Attendance
Course opens: 
07/12/2023
Course expires: 
01/19/2024
Event starts: 
07/12/2023 - 12:00am CDT
Event ends: 
07/14/2023 - 11:00pm CDT
Cost:
$0.00
Rating: 
0
UT Southwestern Medical Center
Dallas, TX
United States
Committee member(s)

Kajal Desai, Department Administrator

has no relevant financial relationships to disclose at this time.

paul medin, PhD, DABR

has no relevant financial relationships to disclose at this time.

Robert Timmerman, MD

has no relevant financial relationships to disclose at this time.

Zabi Wardak, MD

has no relevant financial relationships to disclose at this time.
Course Director(s)

paul medin, PhD, DABR

has no relevant financial relationships to disclose at this time.

Robert Timmerman, MD

has no relevant financial relationships to disclose at this time.

Zabi Wardak, MD

has no relevant financial relationships to disclose at this time.
Peer reviewer(s)

paul medin, PhD, DABR

has no relevant financial relationships to disclose at this time.

Robert Timmerman, MD

has no relevant financial relationships to disclose at this time.
Planner(s)

Nana Ofosu-Appiah

has no relevant financial relationships to disclose at this time.
Speaker(s)

Todd Aguilera, M.D. Ph.D.

has a financial relationship (Intellectual Property Other) with UC San Diego;.
has a financial relationship (Grant Or Contract) with Galera Therapeutics;.
has a financial relationship (Stock) with Avelas Biosciences;.
has a financial relationship (Grant Or Contract) with iTeos;.
has a financial relationship (Intellectual Property Other) with Stanford University ;.
has a financial relationship (Grant Or Contract) with Apexigen Inc;.

Mona Arbab

has no relevant financial relationships to disclose at this time.

Thomas Banks, PhD, DABR

has no relevant financial relationships to disclose at this time.

Eric Chambers, MBA, BSRT (T), CPHQ

has no relevant financial relationships to disclose at this time.

Jeffrey Dubas

has no relevant financial relationships to disclose at this time.

Aurelie Garant, M.D.

has no relevant financial relationships to disclose at this time.

Andrew Godley, PhD Physics, ABR certified in Therapeutic Medical Physics

has no relevant financial relationships to disclose at this time.

Raquibul Hannan, MD, PhD, Associate Professor

has no relevant financial relationships to disclose at this time.

Mu-han Lin

has no relevant financial relationships to disclose at this time.

paul medin, PhD, DABR

has no relevant financial relationships to disclose at this time.

David Parsons, PhD, DABR

has no relevant financial relationships to disclose at this time.

David Sher, MD, MPH

has a financial relationship (Grant Or Contract) with Varian Medical Systems;.

Michael Story, PhD

has a financial relationship (Grant Or Contract) with Galera Therapeutics;.
has a financial relationship (Grant Or Contract) with Novocure;.

Robert Timmerman, MD

has no relevant financial relationships to disclose at this time.

Zabi Wardak, MD

has no relevant financial relationships to disclose at this time.

Yuanyuan Zhang, MD. PhD

has a financial relationship (Grant Or Contract) with Astra Zeneca;.

The University of Texas Southwestern Medical Center at Dallas is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Texas Southwestern Medical Center designates this live activity for a maximum of `19.5 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Available Credit

  • 19.50 AMA
  • 19.50 Attendance

Price

Cost:
$0.00
Please login or create an account to take this course.